RAC 4.32% $1.55 race oncology ltd

Ann: Appendix 4E & Annual Report, page-29

  1. 649 Posts.
    lightbulb Created with Sketch. 296
    https://hotcopper.com.au/data/attachments/4636/4636060-ebea10a5e65d34f18a90a408ca2a2d2a.jpg
    https://hotcopper.com.au/data/attachments/4636/4636071-94fac5eccd05a8acc16dbd1d71a3da1f.jpg
    https://hotcopper.com.au/data/attachments/4636/4636075-3d84eca7d075e7656b27b30e971b9003.jpg

    A couple of items that caught my eye.

    The language around commercial arrangements for Zantrene has changed. Intially the language was around a sale price, but now management seems open to sale, partnerships or licensing (I think the smarter posters on HC have picked this up 6 months ago)

    'At the apppropriate time' is also interesting language, tempering short-term expectations and being realistic on the time frame here. IMO great language, as I believe it was getting a bit pumpish in language last year.

    Great to see accounting fees materially up on PY. That would capture the 6 months expense for the virtual CFO from PKF (Started Jan 2022). Hopefully she is driving the financial modelling and the board can focus on operations.



 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.55
Change
-0.070(4.32%)
Mkt cap ! $264.0M
Open High Low Value Volume
$1.62 $1.65 $1.54 $145.6K 91.60K

Buyers (Bids)

No. Vol. Price($)
2 5700 $1.55
 

Sellers (Offers)

Price($) Vol. No.
$1.59 296 1
View Market Depth
Last trade - 16.10pm 31/07/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.